Pages that link to "Q52325069"
Jump to navigation
Jump to search
The following pages link to Pharmacologic modification of tumor blood flow and interstitial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. (Q52325069):
Displaying 30 items.
- Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid (Q26799981) (← links)
- Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow. (Q30482804) (← links)
- Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers (Q30542073) (← links)
- Acute effects of vascular modifying agents in solid tumors assessed by noninvasive laser Doppler flowmetry and near infrared spectroscopy (Q30835449) (← links)
- Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs (Q33746856) (← links)
- Mild Elevation of Body Temperature Reduces Tumor Interstitial Fluid Pressure and Hypoxia and Enhances Efficacy of Radiotherapy in Murine Tumor Models (Q33879424) (← links)
- Pharmacological aspects of targeting cancer gene therapy to endothelial cells (Q34180767) (← links)
- Delivery of molecular and cellular medicine to solid tumors (Q34190339) (← links)
- Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function (Q34328543) (← links)
- Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules (Q35067308) (← links)
- Drug delivery and transport to solid tumors (Q35563687) (← links)
- Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy (Q35975832) (← links)
- Interstitial fluid pressure in intracranial tumours in patients and in rodents (Q36116465) (← links)
- Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts (Q36135861) (← links)
- Phase I trial of cisplatin, pemetrexed, and imatinib mesylate in chemonaive patients with unresectable malignant pleural mesothelioma (Q37367634) (← links)
- Cardiovascular medications in angiogenesis--how to avoid the sting in the tail (Q38001305) (← links)
- Biphasic effects of propranolol on tumour growth in B16F10 melanoma-bearing mice (Q39238169) (← links)
- Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studies (Q40174625) (← links)
- 1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors (Q41139696) (← links)
- Imaging intratumoral convection: pressure-dependent enhancement in chemotherapeutic delivery to solid tumors (Q41899901) (← links)
- Semiquantitative imaging measurement of baseline and vasomodulated normal prostatic blood flow using sildenafil (Q42649312) (← links)
- Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. (Q47863448) (← links)
- Effective cancer targeting using an anti-tumor tissue vascular endothelium-specific monoclonal antibody (TES-23). (Q54966022) (← links)
- Delivery of molecular and cellular medicine to solid tumors (Q73850199) (← links)
- Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI (Q77181582) (← links)
- Delivery of molecular and cellular medicine to solid tumors (Q77314470) (← links)
- Delivery of molecular and cellular medicine to solid tumors (Q87260307) (← links)
- Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial (Q89540121) (← links)
- A thermoporoelastic model for fluid transport in tumour tissues (Q92352026) (← links)
- Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma (Q98237765) (← links)